Johnson & Johnson is once again confronting a pivotal moment as it attempts to settle lawsuits linked to its baby powder’s alleged cancer risks. The pharmaceutical giant has put forth a $10 billion proposal, seeking the court’s approval to finalize the longstanding litigation through a subsidiary’s bankruptcy proceedings.
About the Author
